Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.825
Peer-review started: September 27, 2022
First decision: October 20, 2022
Revised: October 29, 2022
Accepted: January 11, 2023
Article in press: January 11, 2023
Published online: February 7, 2023
Processing time: 132 Days and 1 Hours
Core Tip: Secondary osteoporosis and increased bone fragility are frequently overlooked complications in patients with chronic liver disease (CLD). Recent publications agree that CLD-induced bone fragility depends on the etiology, duration, and stage of liver disease, but certain ambiguities are still present. Importantly, etiopathogenetic mechanisms leading to CLD-induced bone loss are still insufficiently clarified. Given that available clinical tools for fracture risk assessment are not entirely reliable, evaluating small-length structural bone properties could improve understanding of the multifactorial nature of bone fragility in CLD patients, which could set a base for the development of more effective preventive and therapeutic strategies.
